Last reviewed · How we verify
NCT04307212
How Exercise Signals Health Responses
NA trial testing 50% heart rate reserve (HRR) low intensity exercise in Overweight in 41 participants. Completed in 12 September 2023.
12 September 2023
Quick facts
| Lead sponsor | USDA Grand Forks Human Nutrition Research Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | other |
| Enrollment | 41 |
| Start date | 10 January 2020 |
| Primary completion | 12 September 2023 |
| Estimated completion | 12 September 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 50% heart rate reserve (HRR) low intensity exercise
- 75% HRR moderate intensity exercise
- Control no exercise
Conditions studied
- Overweight — all drugs for Overweight →
Sponsor
USDA Grand Forks Human Nutrition Research Center
Who can join
Adults 18 to 50, any sex, with Overweight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this research is to determine the blood signals that promote health and well-being in response to exercise at different intensities.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04307212
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Overweight
Currently open trials in the same condition.
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
- NCT07465965 — A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults · Phase 1 · recruiting
- NCT07407348 — A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the · Phase 1 · recruiting
- NCT07400653 — A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) · Phase 3 · recruiting
Other USDA Grand Forks Human Nutrition Research Center trials
Trials by the same sponsor.
- NCT06674642 — Traditional Indigenous Foods Diet and Health Study · NA · completed
- NCT06123208 — Impact of Eating Beans on Metabolism · NA · completed
- NCT05612412 — Exercise for Better Bones - Day or Night? · NA · terminated
- NCT05938894 — Train Your Brain - Executive Function · NA · completed
- NCT06096636 — National Survey of Young Adult Nutrition · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04307212 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by USDA Grand Forks Human Nutrition Research Center
- Last refreshed: 11 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04307212.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing